Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;13(3):811-821.
doi: 10.1007/s13346-022-01242-2. Epub 2022 Oct 4.

Efficiency of targeted delivery of streptokinase based on fibrin-specific liposomes in the in vivo experiment

Affiliations

Efficiency of targeted delivery of streptokinase based on fibrin-specific liposomes in the in vivo experiment

Adzerikho Igor et al. Drug Deliv Transl Res. 2023 Mar.

Abstract

Acute thrombosis has a narrow therapeutic window and remains the leading cause of morbidity and mortality, while thrombolytic therapy has limited efficacy and risk of side effects. We have developed and investigated new fibrin-specific systems for local drug delivery to increase efficiency while minimizing the side effects of streptokinase. The experiment was carried out on dogs with 2-h thrombi in the femoral artery received intravenous injections of streptokinase, liposome-bound and free streptokinase at 40/60% ratio, and immunoliposomes. The completeness of the vessel lumen restoration affected by the thrombus, and the risks of side effects were assessed. Fibrinolytic parameters (plasminogen, fibrinogen, alpha2-antiplasmin, and D-dimers levels) were measured at several time points after thrombus induction and the administration of the drug. There was a strong activation of fibrinolysis and consumption of fibrinolysis inhibitors after therapy with all liposomal forms of streptokinase. According to the ultrasound data, immunoliposomal form of streptokinase significantly reduces the degree of residual stenosis to 32% [30.5; 33.7] in 180 min after injection. The high fibrinolytic effect of liposomal forms of streptokinase is not accompanied by a sharp drop in the fibrinogen concentration in the blood compared to the native streptokinase by 60 min. The morphometric evaluation of the artery samples showed that immunoliposomal form of streptokinase induces a significant increase in the degree of free vascular lumen compared to the native streptokinase (71.3% (62.7; 77.5) vs. 47.7% (39.6; 55.7), p < 0.001). Thus, the study shows the efficacy of streptokinase-induced thrombolysis using immunoliposomal form of drug delivery system. Mechanism of action of the immunoliposomal delivery system.

Keywords: Fibrin-specific monoclonal antibodies; Fibrinolysis; Immunoliposome; Liposome; Local delivery system; Streptokinase.

PubMed Disclaimer

References

    1. Korin N, Kanapathipillai M, Matthews BD, Crescente M, Brill A, Mammoto T, et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science. 2012;337(6095):738–42. https://doi.org/10.1126/science.1217815 . - DOI
    1. Pitek AS, Park J, Wang Y, Gao H, Hu H, Simon DI, et al. Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage. Nanoscale. 2018;10(35):16547–55. https://doi.org/10.1039/c8nr02861c . - DOI
    1. Lippi G, Mattiuzzi C, Favaloro EJ. Novel and emerging therapies: thrombus-targeted fibrinolysis. Semin Thromb Hemost. 2013;39(1):48–58. https://doi.org/10.1055/s-0032-1328935 . - DOI
    1. McCarthy JR, Sazonova IY, Erdem SS, Hara T, Thompson BD, Patel P, et al. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy. Nanomedicine (Lond). 2012;7(7):1017–28. https://doi.org/10.2217/nnm.11.179 . - DOI
    1. Kunamneni A, Durvasula R. Streptokinase-a drug for thrombolytic therapy: a patent review. Recent Adv Cardiovasc Drug Discov. 2014;9(2):106–21. https://doi.org/10.2174/1574890110999150202150017 . - DOI

Publication types

LinkOut - more resources